Taysha Gene Therapies (TSHA) Competitors $2.40 -0.03 (-1.23%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$2.48 +0.08 (+3.13%) As of 07/3/2025 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TSHA vs. HHH, APGE, CGON, AGIO, INDV, IRON, BLTE, IDYA, HRMY, and ADPTShould you be buying Taysha Gene Therapies stock or one of its competitors? The main competitors of Taysha Gene Therapies include Howard Hughes (HHH), Apogee Therapeutics (APGE), CG Oncology (CGON), Agios Pharmaceuticals (AGIO), Indivior (INDV), Disc Medicine (IRON), Belite Bio (BLTE), IDEAYA Biosciences (IDYA), Harmony Biosciences (HRMY), and Adaptive Biotechnologies (ADPT). Taysha Gene Therapies vs. Its Competitors Howard Hughes Apogee Therapeutics CG Oncology Agios Pharmaceuticals Indivior Disc Medicine Belite Bio IDEAYA Biosciences Harmony Biosciences Adaptive Biotechnologies Taysha Gene Therapies (NASDAQ:TSHA) and Howard Hughes (NYSE:HHH) are related companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends. Which has preferable valuation and earnings, TSHA or HHH? Howard Hughes has higher revenue and earnings than Taysha Gene Therapies. Taysha Gene Therapies is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTaysha Gene Therapies$8.33M61.85-$89.30M-$0.34-7.06Howard Hughes$1.75B2.00$200.55M$5.2113.32 Is TSHA or HHH more profitable? Howard Hughes has a net margin of 14.27% compared to Taysha Gene Therapies' net margin of -1,201.08%. Howard Hughes' return on equity of 10.21% beat Taysha Gene Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Taysha Gene Therapies-1,201.08% -104.93% -50.09% Howard Hughes 14.27%10.21%3.08% Do insiders and institutionals hold more shares of TSHA or HHH? 77.7% of Taysha Gene Therapies shares are held by institutional investors. Comparatively, 93.8% of Howard Hughes shares are held by institutional investors. 3.8% of Taysha Gene Therapies shares are held by insiders. Comparatively, 33.0% of Howard Hughes shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts recommend TSHA or HHH? Taysha Gene Therapies currently has a consensus price target of $8.20, suggesting a potential upside of 241.67%. Howard Hughes has a consensus price target of $80.33, suggesting a potential upside of 15.78%. Given Taysha Gene Therapies' stronger consensus rating and higher possible upside, analysts clearly believe Taysha Gene Therapies is more favorable than Howard Hughes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Taysha Gene Therapies 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Howard Hughes 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more risk and volatility, TSHA or HHH? Taysha Gene Therapies has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Howard Hughes has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Does the media prefer TSHA or HHH? In the previous week, Taysha Gene Therapies had 2 more articles in the media than Howard Hughes. MarketBeat recorded 5 mentions for Taysha Gene Therapies and 3 mentions for Howard Hughes. Howard Hughes' average media sentiment score of 1.40 beat Taysha Gene Therapies' score of 0.47 indicating that Howard Hughes is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Taysha Gene Therapies 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Howard Hughes 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHoward Hughes beats Taysha Gene Therapies on 11 of the 16 factors compared between the two stocks. Get Taysha Gene Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for TSHA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TSHA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TSHA vs. The Competition Export to ExcelMetricTaysha Gene TherapiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$521.63M$3.92B$5.53B$8.95BDividend YieldN/A1.19%5.38%4.08%P/E Ratio-7.067.5127.4020.24Price / Sales61.8511.19419.60118.25Price / CashN/A6.5236.6357.47Price / Book6.862.698.085.67Net Income-$89.30M-$109.62M$3.16B$248.47M7 Day Performance0.84%3.27%2.84%3.32%1 Month Performance-13.98%6.53%3.69%5.20%1 Year Performance11.63%44.29%35.30%21.35% Taysha Gene Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TSHATaysha Gene Therapies3.3724 of 5 stars$2.40-1.2%$8.20+241.7%+11.6%$521.63M$8.33M-7.06180Analyst ForecastHHHHoward Hughes2.6677 of 5 stars$67.38-0.6%$80.33+19.2%+7.1%$3.42B$1.75B12.93608APGEApogee Therapeutics2.8763 of 5 stars$43.43+0.1%$94.60+117.8%+26.8%$2.00BN/A0.0091News CoverageAnalyst ForecastInsider TradeHigh Trading VolumeCGONCG Oncology2.3934 of 5 stars$26.00+0.2%$58.67+125.6%-12.8%$1.98B$1.14M0.0061AGIOAgios Pharmaceuticals4.0732 of 5 stars$33.26-0.6%$58.60+76.2%-14.2%$1.94B$36.50M2.96390Insider TradeINDVIndivior2.1049 of 5 stars$14.74+5.7%$17.00+15.3%+5.4%$1.92B$1.19B8.161,051High Trading VolumeIRONDisc Medicine3.0891 of 5 stars$52.96-2.8%$96.70+82.6%+23.2%$1.89BN/A0.0030Analyst ForecastBLTEBelite Bio2.4985 of 5 stars$57.70-2.3%$96.67+67.5%+30.6%$1.88BN/A0.0010Analyst ForecastGap UpIDYAIDEAYA Biosciences3.5468 of 5 stars$21.02-1.6%$53.42+154.1%-33.6%$1.87B$7M0.0080HRMYHarmony Biosciences4.5693 of 5 stars$31.60-1.2%$53.63+69.7%+3.9%$1.84B$714.73M12.21200ADPTAdaptive Biotechnologies3.4511 of 5 stars$11.65-1.2%$10.57-9.3%+253.3%$1.79B$178.96M-12.14790Gap Up Related Companies and Tools Related Companies HHH Alternatives APGE Alternatives CGON Alternatives AGIO Alternatives INDV Alternatives IRON Alternatives BLTE Alternatives IDYA Alternatives HRMY Alternatives ADPT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TSHA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taysha Gene Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taysha Gene Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TSHA Stock Alerts